Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Plinabulin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Beyondspring Presents Plinabulin And ADC Combo Poster At AACR
    Beyondspring Presents Plinabulin And ADC Combo Poster At AACR

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264525/0/en/BeyondSpring-Announces-Plinabulin-and-ADC-Combination-Poster-Presentation-at-AACR-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Beyondspring Reports 2025 Year-End Financial Results
    Beyondspring Reports 2025 Year-End Financial Results

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262191/0/en/BeyondSpring-Reports-2025-Year-End-Financial-Results.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Beyondspring To Attend 12Th Immuno-Oncology 360° Conference
    Beyondspring To Attend 12Th Immuno-Oncology 360° Conference

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234417/0/en/BeyondSpring-to-Participate-at-the-12th-Annual-Immuno-Oncology-360-Conference.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Beyondspring Presents Plinabulin + Docetaxel Data At ESMO Asia
    Beyondspring Presents Plinabulin + Docetaxel Data At ESMO Asia

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204554/0/en/BeyondSpring-Announces-ESMO-Asia-Presentation-on-Plinabulin-Docetaxel-Improving-Survival-in-Large-Phase-3-DUBLIN-3-Asian-Subset-for-EGFR-WT-NSCLC-Compared-to-Docetaxel-Strengthenin.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Beyondspring Reveals Ph3 of Plinabulin+Docetaxel Survival Benefit
    Beyondspring Reveals Ph3 of Plinabulin+Docetaxel Survival Benefit

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203772/0/en/BeyondSpring-Announces-New-Analyses-of-DUBLIN-3-Phase-3-Study-Showing-Survival-Benefit-of-Plinabulin-Docetaxel-in-Post-Anti-PD-L-1-for-Non-squamous-EGFR-WT-NSCLC-and-a-Reduction-in.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    BeyondSpring's Plinabulin Drives Dendritic Cell Maturation
    BeyondSpring's Plinabulin Drives Dendritic Cell Maturation

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3110902/0/en/BeyondSpring-Publishes-Human-Clinical-Study-in-Med-Cell-Press-Showing-Plinabulin-Driven-Dendritic-Cell-Maturation-and-Tumor-Response-After-Prior-Checkpoint-Inhibitor-Failure.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.